Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Accounts Payables (2017 - 2025)

Historic Accounts Payables for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to $507524.0.

  • Cirtran's Accounts Payables fell 2329.31% to $507524.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $507524.0, marking a year-over-year decrease of 2329.31%. This contributed to the annual value of $762440.0 for FY2024, which is 2182.51% up from last year.
  • Latest data reveals that Cirtran reported Accounts Payables of $507524.0 as of Q3 2025, which was down 2329.31% from $766922.0 recorded in Q2 2025.
  • In the past 5 years, Cirtran's Accounts Payables registered a high of $2.3 million during Q3 2023, and its lowest value of $507524.0 during Q3 2025.
  • Moreover, its 5-year median value for Accounts Payables was $1.6 million (2021), whereas its average is $1.4 million.
  • In the last 5 years, Cirtran's Accounts Payables skyrocketed by 4274.14% in 2021 and then plummeted by 7306.93% in 2023.
  • Over the past 5 years, Cirtran's Accounts Payables (Quarter) stood at $1.9 million in 2021, then rose by 20.79% to $2.3 million in 2022, then tumbled by 73.07% to $625848.0 in 2023, then grew by 21.83% to $762440.0 in 2024, then plummeted by 33.43% to $507524.0 in 2025.
  • Its last three reported values are $507524.0 in Q3 2025, $766922.0 for Q2 2025, and $747126.0 during Q1 2025.